Activation of c-SRC underlies the differential effects of ouabain and digoxin on Ca2+ signaling in arterial smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 4, 2013, Pages

  Zulian, Alessandra ^a   Linde, Cristina I ^a   Pulina, Maria V ^a   Baryshnikov, Sergey G ^a   Papparella, Italia ^a   Hamlyn, John M ^a   Golovina, Vera A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiotonic steroids; Na+ pumps; NCX1; Receptoroperated Ca2+ entry; TRPC proteins

Indexed keywords

DIGOXIN; OUABAIN; PROTEIN KINASE P60;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTERY MUSCLE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOBLOTTING; IN VIVO STUDY; MESENTERIC ARTERY; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CALCIUM CHANNELS; CALCIUM SIGNALING; CARDIOTONIC AGENTS; CELLS, CULTURED; DIGOXIN; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NIFEDIPINE; OUABAIN; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-CALCIUM EXCHANGER; SODIUM-POTASSIUM-EXCHANGING ATPASE; SRC-FAMILY KINASES; TRPC CATION CHANNELS;

EID: 84874091108     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00337.2012     Document Type: Article

References (64)

1. Abarquez RF Jr. Digitalis in the treatment of hypertension. A preliminary report. Acta Med Philipp 3: 161-170, 1967.
2. Abram CL, Courtneidge SA. Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254: 1-13, 2000.
3. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27: 178-186, 2006.
4. Bae YM, Kim A, Lee YJ, Lim W, Noh YH, Kim EJ, Kim J, Kim TK, Park SW, Kim B, Cho SI, Kim DK, Ho WK. Enhancement of receptoroperated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 25: 809-817, 2007.
5. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev 61: 9-38, 2009.
6. + ATPase by cardiac glycosides and by a mammalian digitalis like factor. Life Sci 67: 1921-1928, 2000.
7. Beech DJ, Muraki K, Flemming R. Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP. J Physiol 559: 685-706, 2004.
8. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295: C779-C790, 2008.
9. +-ATPase, Jerusalem, Israel (Abstract), 2011.
10. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol Cell Physiol 232: C165-C173, 1977.
11. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J, Wier WG. How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 302: H1031-H1049, 2012.
12. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP, Izuka M, Iwamoto T, Kotlikoff MI, Lingrel JB, Philipson KD, Wier WG, Hamlyn JM. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 53: 291-298, 2009.
13. DeWire SM, Violin JD. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology. Circ Res 109: 205-216, 2011.
14. Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102: 15845-15850, 2005.
15. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, Lingrel JB. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477-H485, 2005.
16. Ferrandi M, Manunta P, Balzan S, Hamlyn JM, Bianchi G, Ferrari P. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 30: 886-896, 1997.
17. Golovina VA, Blaustein MP. Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies. Nat Protoc 1: 2681-2687, 2006.
18. 2+ signaling. Am J Physiol Cell Physiol 284: C475-C486, 2003.
19. Guthrie GP Jr. Effects of digoxin on responsiveness to the pressor actions of angiotensin and norepinephrine in man. J Clin Endocrinol Metab 58: 76-80, 1984.
20. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci 19: 935-947, 1976.
21. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263, 1991.
22. Hisatsune C, Kuroda Y, Nakamura K, Inoue T, Nakamura T, Michikawa T, Mizutani A, Mikoshiba K. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J Biol Chem 279: 18887-18894, 2004.
23. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397: 259-263, 1999.
24. Huang BS, Kudlac M, Kumarathasan R, Leenen FH. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 34: 733-738, 1999.
25. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10: 1193-1199, 2004.
26. Kaide J, Ura N, Torii T, Nakagawa M, Takada T, Shimamoto K. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats. Am J Hypertens 12: 611-619, 1999.
27. 2+ entry channels. Proc Natl Acad Sci USA 103: 335-340, 2006.
28. Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336: 296-302, 2011.
29. Kimura K, Manunta P, Hamilton BP, Hamlyn JM. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res 23, Suppl: S67-S76, 2000.
30. Kurashina T, Kirchner KA, Granger JP, Patel AR. Chronic sodium potassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat. Clin Sci (Lond) 91: 497-502, 1996.
31. 2+ of agonist-stimulated divalent cation entry from the refilling of the agonist sensitive intracellular pool. J Biol Chem 265: 678-684, 1990.
32. Li Z, Xie Z. The Na/K-ATPase/Src complex and cardiotonic steroidactivated protein kinase cascades. Pflügers Arch 457: 635-644, 2009.
33. Liang M, Cai T, Tian J, Qu W, Xie ZJ. Functional characterization of Src interacting Na/K-ATPase using RNA interference assay. J Biol Chem 281: 19709-19719, 2006.
34. 2+ signaling, vasoconstriction, and myogenic reactivity in Milan hypertensive rats. Am J Physiol Heart Circ Physiol 302: H611-H620, 2012.
35. Liu J, Xie ZJ. The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim Biophys Acta 1802: 1237-1245, 2010.
36. +-ATPase. Biochemistry 50: 8664-8673, 2011.
37. +-ATPase subunit. Am J Physiol Heart Circ Physiol 295: H273-H280, 2008.
38. Manunta P, Ferrandi M, Bianchi G, Hamlyn JM. Endogenous ouabain in cardiovascular function and disease. J Hypertens 27: 9-18, 2009.
39. Manunta P, Hamilton J, Rogowski AC, Hamilton BP, Hamlyn JM. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23, Suppl: S77-S85, 2000.
40. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabaininduced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 12: 549-560, 1994.
41. Mason DT. Effects of cardiac glycoside on vascular system. In: Cardiac Glycosides. Part 1: Experimental Pharmacology, edited by Greef F. New York: Springer, 1981 p. 497-515.
42. +)-ATPase isozymes for cardioactive steroids, role of lactone ring, sugar moiety and KCl concentration. Biochem Pharmacol 40: 2611-2616, 1990.
43. O'Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys 310: 32-39, 1994.
44. Oda Y, Renaux B, Bjorge J, Saifeddine M, Fujita DJ, Hollenberg MD. cSrc is a major cytosolic tyrosine kinase in vascular tissue. Can J Physiol Pharmacol 77: 606-617, 1999.
45. Pierre SV, Sottejeau Y, Gourbeau JM, Sanchez G, Shidyak A, Blanco G. Isoform specificity of Na-K-ATPase-mediated ouabain signaling. Am J Physiol Renal Physiol 294: F859-F866, 2008.
46. 2+ transporters in arterial smooth muscle from ouabain hypertensive rats. Am J Physiol Heart Circ Physiol 298: H263-H274, 2010.
47. Raina H, Zhang Q, Rhee AY, Pallone TL, Wier WG. Sympathetic nerves and endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries. Am J Physiol Heart Circ Physiol 298: H2093-H2101, 2010.
48. Rossi G, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens 13: 1181-1191, 1995.
49. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293: C509-C536, 2007.
50. Schulte KL, van Gemmeren D, Thiede HM, Meyer-Sabellek W, Gotzen R, Distler A. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline. J Hypertens Suppl 5: S215-S218, 1987.
51. + pump alpha 2-isoform specifically couples to contractility in vascular smooth muscle: evidence from gene-targeted neonatal mice. Am J Physiol Cell Physiol 286: C813-C820, 2004.
52. +-ATPase forms a functional signaling complex. Mol Biol Cell 17: 317-326, 2006.
53. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens 19: 441-449, 2001.
54. Vazquez G, Wedel BJ, Kawasaki BT, Bird GS, Putney JW Jr. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem 279: 40521-40528, 2004.
55. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, Bianchi G, Manunta P. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 21: 1475-1481, 2003.
56. Wang Z, Zheng M, Li Z, Li R, Jia L, Xiong X, Southall N, Wang S, Xia M, Austin CP, Zheng W, Xie Z, Sun Y. Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res 69: 6556-6564, 2009.
57. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.
58. Withering W. An Account of the Foxglove and Some of Its Medical Uses: With Practical Remarks on Dropsy and Other Diseases. London: Robinson, p. 207, 1785.
59. 2+ exchanger expression in adult cardiomyocytes. J Mol Cell Cardiol 38: 735-743, 2005.
60. Yoda A. Association and dissociation rate constants of the complexes between various cardiac monoglycosides and Na, K-ATPase. Ann NY Acad Sci 242: 598-616, 1974.
61. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ, Pamnani MB. Long-term ouabain administration produces hypertension in rats. Hypertension 22: 178-187, 1993.
62. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243-256, 2005.
63. 2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol 298: H1472-H1483, 2010.
64. 2+ homeostasis in arterial smooth muscle cells from Milan hypertensive rats. Am J Physiol Heart Circ Physiol 299: H624-H633, 2010.